Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 2C6H5O7.Fe.4Na |
| Molecular Weight | 526.003 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].[Na+].[Na+].[Na+].[Fe++].OC(CC([O-])=O)(CC([O-])=O)C([O-])=O.OC(CC([O-])=O)(CC([O-])=O)C([O-])=O
InChI
InChIKey=JHYAVWJELFKHLM-UHFFFAOYSA-H
InChI=1S/2C6H8O7.Fe.4Na/c2*7-3(8)1-6(13,5(11)12)2-4(9)10;;;;;/h2*13H,1-2H2,(H,7,8)(H,9,10)(H,11,12);;;;;/q;;+2;4*+1/p-6
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Palliative | Unknown Approved UseUnknown |
|||
| Palliative | Unknown Approved UseUnknown |
|||
| Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
| Title | Date | PubMed |
|---|---|---|
| FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS. | 1932 Jul 1 |
|
| FERROUS IODIDE AND LINOLEIC ACID IN VITAMIN A DEFICIENCY. A REPLY TO CERTAIN CRITICISMS. | 1932 Nov 11 |
|
| THE USE OF FERROUS GLUCONATE IN THE TREATMENT OF HYPOCHROMIC ANEMIA. | 1937 Jul |
|
| [Ferrous lactate as an oral iron preparation for therapeutic use]. | 1954 Nov 27 |
|
| Clinical appraisal of drugs with special reference to a new chelate hematinic. | 1957 Jul 11 |
|
| [FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
| Decreased treatment failure rates following duodenal release ferrous glycine sulfate in iron deficiency anemia associated with autoimmune gastritis and Helicobacter pylori gastritis. | 2007 |
|
| Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. | 2009 |
|
| The effect of iron treatment on adhesion molecules in patients with iron deficiency anemia. | 2010 Dec |
|
| Tolerability of different oral iron supplements: a systematic review. | 2013 Apr |
|
| A practical and successful desensitization protocol for immediate hypersensitivity reactions to iron salts. | 2014 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB16461MIG
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
100000078588
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
441
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
DTXSID90195752
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
43160-25-4
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
50717-86-7
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
ALTERNATIVE | |||
|
71587155
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY | |||
|
FIZ06U7B2G
Created by
admin on Sat Dec 16 19:58:34 GMT 2023 , Edited by admin on Sat Dec 16 19:58:34 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
